Singapore Daily Briefing

SGX disclosed an IPO pipeline of approximately 50 companies in various stages of readiness alongside its record FY2026 results — revenue +13.9% to S$1.5 billion, net profit +7.8% to S$698.4 million. The IPO pipeline figure is strategically important: SGX has been competing directly with HKEX for Greater China listings, and a pipeline of 50 ready-stage companies suggests the exchange's listing incentives and governance frameworks are attracting issuers. For Singapore investors, a robust IPO pipeline alongside record derivatives volumes sets up continued fee income growth in H1 FY2027.

DeepSeek's US$20.8 million strategic investment in Unitree Robotics' Shanghai IPO is a significant cross-sector signal: China's leading AI model developer is backing hardware robotics infrastructure at the IPO stage. For Singapore investors tracking the AI-robotics convergence theme, this investment validates that China's AI ecosystem is moving from software-model competition into embodied AI and physical automation applications. SGX's own derivatives exposure to China tech names means any acceleration in Chinese AI-robotics investment activity would flow through to SGX's Northbound-linked derivatives volumes.

US markets opened weaker with S&P 500 and Nasdaq under pressure from tech sector leadership erosion — Alphabet's 5% decline on chief scientist Jeff Dean's departure is the most significant single-stock negative catalyst. For Singapore investors with US tech ADR exposure, the Alphabet sell-off and broader Middle East geopolitical risk context provide the external risk backdrop that prevented an even stronger Singapore session gain. Watch whether the US session closes with tech stabilization, which would reduce tomorrow's Asia open headwinds.